Abstract:DNA damage can lead to mutations that can alter the function of oncogenes or tumor suppressor genes, thus promoting the development of cancer. p53 plays a multifaceted and complex role in the DNA damage response and cancer progression and is known as the 'guardian of the gene'. When DNA damage occurs, p53 is activated through a series of post-translational modifications, which stabilize the protein and enhance its function as a transcription factor. It regulates processes including cell cycle checkpoints, DNA repair and apoptosis, thereby preventing the spread of damaged DNA and maintaining genome integrity. On the one hand, p53 can initiate cell cycle arrest and induce cells to enter the G1/S and G2/M checkpoints, preventing cells with damaged DNA from continuing to proliferate and gaining time for DNA repair. At the same time, p53 can promote the activation of DNA repair pathways, including base excision repair, nucleotide excision repair and other repair pathways, to ensure the integrity of genetic material. If the damage is too severe to repair, p53 will trigger the apoptosis process to eliminate potential cancer risks in time. p53 also plays a pivotal role in cancer progression. Mutations in the p53 gene are frequently found in many cancers, and the mutated p53 not only loses its normal tumor suppressor function but may even acquire pro-cancer activity. Therefore, we also discuss therapeutic strategies targeting the p53 pathway, such as the use of small-molecule drugs to restore the function of wild-type p53, the inhibition of negative regulatory factors and synthetic lethality approaches for p53-deficient tumors. This review therefore highlights the important role of p53 in maintaining genomic stability and its potential in therapeutic strategies for cancer.

The first 30 years of p53: growing ever more complex

p53: 800 million years of evolution and 40 years of discovery

p53: A tale of complexity and context

Putting p53 in Context

Blinded by the Light: The Growing Complexity of p53

At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Functional Diversity of P53 in Human and Wild Animals

p53 signaling in cancer progression and therapy

Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor

Gene regulation by the tumor suppressor p53 - The omics era

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Understanding the complexity of p53 in a new era of tumor suppression

Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe

TP53: the unluckiest of genes?

Ordered and deterministic cancer genome evolution after p53 loss

The limitless role of p53 in cell cycle machinery: Good news or bad news?

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53

Surfing the p53 network